News

Gilead, Kymera Partner in $750M Deal to Develop Novel Molecular Glue Degraders for Cancer
Gilead Sciences Inc. (NASDAQ:GILD) is one of the undervalued S&P 500 stocks to buy according to hedge funds. On June 25, ...
Kymera’s partnerships with Sanofi and Gilead drive value
The core value driver remains KT-621, Kymera’s STAT6-targeting program. “STAT6 remains [the] primary driver to the story,” ...
Here Are My Top 3 Energy Dividend Stocks to Buy Now
Brookfield Renewable plans to increase its nearly 5% yielding dividend by 5% to 9% per year. ConocoPhillips aims to deliver ...
Exas, Guardant, Gilead among gainers as Supreme Court ensures free preventive care
Labcorp (LH), and Gilead (GILD) rise as Supreme Court upholds right to free preventive care under Obamacare. Read more here.
Boeing’s positive turn ’should enable a reassessment of the stock’ says Redburn
Boeing is entering a new phase of recovery that could support a market reassessment of its stock, according to analysts at Redburn.
Disney target raised at Guggenheim on sports, parks momentum
Guggenheim raised its price target on Walt Disney (NYSE:DIS) Co to $140 from $120 on stronger-than-expected trends across sports advertising, theme parks, and progress on cost-cutting as the company ...